Somatus Raises $11 Million in Series B Financing

Innovative Kidney Care Company works with Health Systems and Payers to enable value-based care for CKD and ESRD populations VIENNA, Va., April 11, 2018 -- (Healthcare Sales &Marketing Network) -- Somatus, an innovative care delivery and management com... Devices, Venture Capital Somatus, Chronic Kidney Disease, End Stage Renal Disease, dialysis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

Conclusion: A comprehensive survey of ESRD patients in a geographical area of 2 million residents identified one undiagnosed case of Fabry disease and led to the identification of 8 additional cases among his relatives. Screening protocols starting from the dialysis population and upstream extended to families of affected individuals may be an effective strategy to maximize the early identification of subjects with Fabry disease.Kidney Blood Press Res 2018;43:1344 –1351
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research
Abstract Since the inception of hemodialysis (HD) for patients with chronic kidney disease, the "perfect" dialysis prescription has remained elusive. Part of this may relate to the heterogeneity among populations, individual patients, and differences in access to health provision. The optimal balance between dialysis frequency and duration to achieve reductions in patient morbidity and mortality continues to be debated. The concept of dialysis adequacy originated from a post hoc mathematical analysis of the National Cooperative Study and has evolved to become a way of calculating dialysis dose and standa...
Source: Seminars in Dialysis - Category: Urology & Nephrology Authors: Tags: Semin Dial Source Type: research
Victorine B Nzana, Anusha Rohit, Deepu George, Madhusudan Vijayan, Milly Mathew, Sundar Sankaran, Palaniappan Nagarajan, Georgi AbrahamIndian Journal of Medical Microbiology 2018 36(2):282-284A 51-year-old female, with non-alcoholic liver cirrhosis, portal hypertension, type 2 diabetes mellitus, autosomal dominant polycystic kidney disease with a clipped cerebral aneurysm and chronic kidney disease stage 5 was on continuous ambulatory peritoneal dialysis (CAPD) for 6.5 years elsewhere. She came for opinion on continuation of CAPD as she had 21 episodes of peritonitis in 76 months. Her blood pressure was 80/50 mmHg. She was...
Source: Indian Journal of Medical Microbiology - Category: Microbiology Authors: Source Type: research
Trace elements, which have a crucial role in metabolism and enzymatic pathways, are not routinely monitored in the blood of pediatric patients with chronic kidney disease. The present study was carried out to determine the serum levels of copper (Cu), zinc (Zn), selenium (Se), and lead (Pb) in children with ESRD who were currently receiving conservative management or were on long-term hemodialysis or continuous ambulatory peritoneal dialysis.
Source: Journal of Renal Nutrition - Category: Urology & Nephrology Authors: Tags: Original Research Source Type: research
Broad adoption of electronic health record (EHR) systems has facilitated acute kidney injury (AKI) research in 2 ways. First, the detection of AKI based on changes in serum creatinine has largely replaced the sensitive but nonspecific administrative coding of AKI that predominated in earlier studies. Second, the ability to implement real-time AKI interventions such as alerts and best-practice advisories has emerged as a promising tool to fight against the harmful sequela of AKI, which include short-term adverse outcomes as well as progression to chronic kidney disease, dialysis, and death. In this review, we discuss the cu...
Source: Nephron - Category: Urology & Nephrology Source Type: research
This study aims to investigate the effect of Bim on the early diagnosis and prognosis of the elderly uremia with gastrointestinal nutrition combined with dialysis. PATIENTS AND METHODS: Elderly patients with uremia in our hospital were selected and divided into parenteral nutrition group, enteral nutrition group, and regular treatment group. Healthy volunteers were chosen as the control group. Blood oxygen free radicals were tested by flow cytometry. Blood immune function parameter C-reactive protein and IL-6 levels were determined by Western blot. Bim expression in blood was evaluated by RT-PCR and Western blot. Corre...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Purpose of review Small-molecule inhibitors of prolyl hydroxylase domain enzymes (PHD inhibitors) are novel renal anemia therapies that increase endogenous erythropoietin (EPO) production by stabilizing hypoxia-inducible factor (HIF). This review summarizes recent findings and future perspectives of PHD inhibitors (HIF stabilizers) in chronic kidney disease (CKD)-associated anemia. Recent findings Clinical trials have demonstrated that HIF stabilizers effectively increase hemoglobin levels of both nondialysis and dialysis CKD patients without causing serious adverse effects. HIF stabilizers not only restore EPO produc...
Source: Current Opinion in Nephrology and Hypertension - Category: Urology & Nephrology Tags: PHARMACOLOGY AND THERAPEUTICS: Edited by Sankar D. Navaneethan Source Type: research
Conclusion: In CKD 5D patients, high-turnover ROD was associated with elevated iPTH at a low cutoff but not with BAP. The same diagnosis in CKD NOD was associated both with iPTH and BAP.Kidney Blood Press Res 2018;43:1222 –1230
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research
WEDNESDAY, Aug. 1, 2018 -- The right diet can slow chronic kidney disease, but 90 percent of patients who do not require dialysis never see a dietitian, new research finds. " Most adults with chronic kidney disease remain poorly informed of how diet...
Source: - Daily MedNews - Category: General Medicine Source Type: news
Publication date: Available online 1 August 2018Source: American Heart JournalAuthor(s): Sripal Bangalore, David J. Maron, Jerome L. Fleg, Sean M. O’Brien, Charles A. Herzog, Gregg W. Stone, Daniel B. Mark, John A. Spertus, Karen P. Alexander, Mandeep S. Sidhu, Glenn M. Chertow, William E. Boden, Judith S. Hochman, on behalf of the ISCHEMIA-CKD Research GroupAbstractBackgroundPatients with chronic kidney disease (CKD) and stable ischemic heart disease (SIHD) are at markedly increased risk of cardiovascular events. Prior trials comparing a strategy of optimal medical therapy (OMT) with or without revascularization hav...
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Chronic Kidney Disease | Dialysis | Marketing | Urology & Nephrology | Venture Capital